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Facile and inexpensive fabrication 
of zinc oxide based bio-surfaces for 
C-reactive protein detection
Lu Cao, Janice Kiely, Martina Piano & Richard Luxton
The paper reports a biosensor formed from antibody coated ZnO nano-crystals which has been prepared 
using a rapid and inexpensive fabrication method which utilises colloidal dispersion enhanced using 
sonication. This technique was used to prepare highly ordered and uniform nano-crystalline sensor 
surfaces on polyethylene terephthalate (PET) using 0.5%, 1% and 5% concentrations of zinc oxide nano-
crystal suspensions. Impedance spectroscopy was employed to interrogate the sensor surfaces and 
confirmed high reproducibility of the fabrication process. Changes in impedance values, at a frequency 
of 138 Hz, were used to establish dose dependent responses for C-reactive protein (CRP) antigen. A limit 
of detection of less than 1 ng/ml was demonstrated for nano-surfaces fabricated from concentrations of 
1% ZnO.
Nanomaterials have been intensively studied and provide an excellent platform for the development of high per-
formance biosensors, due to their unique physio-chemical properties. For example, due to the large surface area 
of nanomaterials, large numbers of capture molecules, such as enzymes1–3, antibodies4, and DNA5, can be immo-
bilised, enhancing sensitivity. Zinc oxide (ZnO) nanoparticles are one of the most important nanomaterials in 
this context, due to their high electron mobility, good chemical stability, low toxicity and biological compatibility6. 
Furthermore, ZnO has a high isoelectric point (pI) of approximately 9.5, which makes it suitable for absorption 
of relatively negatively charged proteins, e.g. enzymes and antibodies with lower pI’s, primarily driven by elec-
trostatic interaction. The majority of reported ZnO-based biosensors are designed for the detection of various 
molecule analytes by electron transfer, such as glucose3,7,8, cholesterol9,10, cortisol11, cardiac troponin (cTnT)12 and 
phenol13. It has been used for detection of pentachlorophenol (PCP) via measuring electrochemiluminescence 
(ECL) intensity at electrode surface caused by electrochemical high-energy electron transfer reaction14. ZnO also 
has been used to fabricate electrochemical impedance sepectroscopy (EIS) based sensors for detection of glu-
cose8. Furthermore, EIS has also been shown to indicate the effect of different cTnT concentrations on the charge 
perturbations at the electrode surfaces12.
From a structural perspective, zinc oxide crystallizes in two main forms, hexagonal wurtzite and cubic zinc 
blende, the wurtzite structure is most stable at ambient conditions and thus most common. ZnO can produce 
a piezoelectric effect once it is strained due to the non-centrosymmetric crystal structure15. The piezoelectric 
constant is strongly sensitive to both temperature and stress16. Because of the role of native point defects and 
impurities, innately ZnO has an n-type conductivity17. A number of methods have been used to synthesize 
ZnO films and other types of nanostructures for biosensors, such as chemical baths18, hydrothermal methods19, 
chemical vapour deposition(CVD)20, Pulsed Laser Deposition(PLD)11, sputtering21, electro-spinning2 and 
sweeping-printing22. However, the preparation of these films and structures, such as nanowires18, nanorods4,9,21, 
nanofibres2 and nanotubes1,23, with desirable electrical/chemical properties remains a technological challenge. 
One example of the complexity of achieving high quality, reproducible structures is described by Sanguino24. They 
used hydrothermal process to gain a high density of ZnO structures deposited on Au microelectrodes, however, 
the lack of deposition time caused the uneven coverage of the electrode24.
Compared with other methods, the technique of colloidal dispersion of ZnO nanoparticles shows both disad-
vantages and advantages. The disadvantage of ZnO nano-crystals is that the crystals easily aggregate. During the 
process of growth, Park et al.25 found that several ZnO crystallites of about 5–10 nm agglomerated and formed 
a horizontal hexagonal platelet, which was a different output compared with other published results. Through 
a comparison of different concentrations (1%, 3%, 5% and 7%) of ZnO dispersions either in water or methanol 
to make the surface of ZnO-polyester composite textile materials, Rimbu et al.26 demonstrated that the larger 
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concentration leads to agglomerations and a diminished coating quality. In order to mitigate the problem of 
aggregation, the process of sonication can be used. For example, in order to fabricate an ultrasensitive biosensor 
for DNA detection, Liu et al.5 employed sonication to achieve water-soluble ZnO/Au nanocomposites. The advan-
tage of the colloidal dispersion techniques is that ZnO nanocrystals of defined shape and size can be purchased 
ensuring that well characterised films can be created via a simple fabrication process.
In this study, we present preliminary results of a new biosensor that utilises a colloidal dispersion technique, 
incorporating sonication, to create a ZnO nanocrystal surface. The advantage of this technique is that biosensor 
surfaces, with controlled compositions and nanostructures, could be created at low cost with standard labora-
tory equipment; the technique also being suitable for large scale synthesis. Impedance spectroscopy was used to 
interrogate the biosensor surface to create a compact biosensor. In order to prove the functionality of the ZnO 
nano-crystal biosensor, C-reactive protein (CRP) was selected as the model antigen. CRP has been shown as a 
biomarker of various health outcomes, such as cardiovascular disease27, obesity28, diabetes29, cerebrovascular 
disease30, chronic kidney disease31, cancer32.
Results and Discussion
Morphological Study. From the SEM images, Fig. 1(a), the 5% ZnO suspension shows a surface with a more 
complete covering of ZnO compared with Fig. 1(b), the 1% ZnO suspension. This observation was as expected 
owing to the larger mass of ZnO applied. Figure 1(c) shows that the surface of 0.5% ZnO nano-crystals on PET is 
significantly different from the 1% and 5%, with abnormal sharp, platelet-like shapes. We postulate that the rela-
tive absorption of ultrasound energy is greater by the crystals when there is a lower mass of ZnO material (0.5% 
ZnO), resulting in the fracture of the ZnO crystals forming the observed sharp platelets. This suggests that the 
size of the composites observed could be due to the sonication-induced aggregation5. In other words, the lower 
concentrations of ZnO suspension are subject to larger sheer forces which may fracture the existing nanocrystal 
structures and subsequent agglomerations result in the formation of the other ZnO nano-structures observed.
From Fig. 2 it is clear that even though the surface is covered with dense nanoparticles, there are still many 
voids resulting in a porous surface. The lower values of grayscale represent darker areas on the image where 
the substrate is revealed and the higher grayscale values represent the lighter areas with a maximum grayscale 
value of 255. The profile plot of 5% ZnO shows the narrowest range of grayscale values compared with 1% and 
0.5%, indicating that the surface of 5% is smoother than the others, with less deep holes and peaks across the 
nano-surface, reflecting the high density of ZnO nanocrystals present. This demonstrates that the colloidal dis-
persion technique and drop method provides uniformed ZnO films with 5% ZnO. In comparison, the 1% ZnO 
nano-surface gave full coverage with ZnO but with a rougher surface, whereas the 0.5% nano-surface showed 
many areas where the grayscale value was zero, indicating deep pits, revealing the underlying PET. The roughness 
index of the 0.5% ZnO nano-surface was calculated to be 8097, the 1% ZnO nano-surface was 10718 and the 5% 
ZnO nano-surface was 2310. These results indicate that 1% ZnO nano-surface has the largest surface area; the 
0.5% ZnO nano-surface had a relatively large surface area but there was incomplete coverage of the PET substrate, 
whereas the 5% nano-surface is the least rough, with the smallest surface area.
Raman Spectroscopy analysis of the surfaces. Figure 3 shows the Raman spectra of bare PET (blue line) 
and PET covered with 1% ZnO nanocrystals (green line). There was a strong correlation with a Raman spectrum 
of pure PET33, two strong, characteristic bands were observed at 1723 cm−1 and 1610 cm−1 which corresponded 
to C=O stretching and benzene ring structures. The band at 854 cm−1 corresponded to the ester C(O)O bending 
mode33. Published Raman spectra of ZnO nanorods34,35, indicate significant bands at 438 cm−1 and 1050 cm−1 
and a few weak bands at 330, 379, 535 and 585 cm−1. The Raman spectrum of the ZnO surface shown in Fig. 3, 
shows that the bands associated with the PET are attenuated due to being covered by ZnO, additional bands are 
seen at 324, 435, 532, 582 and 1050 with the significant bands at 324 cm−1 and 1050 cm−1. These results strongly 
indicate the ZnO nano crystals cover the surface. A Raman peak at 324 cm−1 represents a highly crystalline 
structure in ZnO nanomaterials, while peaks at 584 and 673 cm−1 represent disordered material and impurities36. 
Comparing the intensity of two peaks at 324 and 582 cm−1, the peak at 324 cm−1 was far greater, indicating that 
the nano-surface with ZnO crystals were highly ordered and uniform.
Figure 1. SEM images for ZnO nano-surfaces on PET via suspensions at different amounts of ZnO nano-
crystals: (a) 5% ZnO; (b) 1% ZnO; (c) 0.5% ZnO.
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Figure 4 shows the Raman spectra for 1% ZnO with capture antibody (green line) and for ZnO without the 
capture antibody molecule (blue line). The main goal is to identify antibody on the surface of the ZnO through the 
spectra derived. The anti-Human C-reactive protein, used in this study is an IgG2a isotype. Bands associated with 
antibody were observed at 2937, 2576, 2211, 1125, 999 and 914 cm−1, providing strong evidence that antibody 
is on the surface of the ZnO nanocrystals. Kengne-Momo37 reports that IgG will give bands at 914 cm−1 (CH2 
deformation (ρCH2); 2937 cm−1 (C-H stretching (νC-H) of aliphatic chains). Both of these bands are evident in 
Fig. 4. In addition, the backbone skeletal νC-C vibration bands were observed in the region of 999 to 1125 cm−1.
Figure 2. Plot profiles along a horizontal line within images (mag × 2000) for nano-surfaces made by three 
different concentrations of ZnO suspensions: 0.5%, 1% and 5%.
Figure 3. Raman spectra of bare PET (blue line) and PET covered by 1% ZnO nanocrystals (green line) at room 
temperature. Conditions of recording Raman Spectrum of bare PET: time acquisition 30 s, wavelength 785 nm. 
Conditions of recording Raman Spectrum of nano-ZnO on PET: time acquisition 50 s, wavelength 785 nm.
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Impedance spectroscopy of the surface of the PET with different concentrations of ZnO. 
Impedance spectroscopy of the three ZnO nano-surfaces (from concentrations of ZnO nano-crystals suspensions 
of 5%, 1%, 0.5%) are shown in Fig. 5. The results were plotted based on average impedance value of 24 samples for 
each concentration. These measurements were made on different sensors over a series of days. Fig. 5 shows that 
the average impedance values decreases as the concentrations of ZnO suspension decreases. This is due to the 
high loading of zinc oxide in the 5% sample causing the maximum perturbation of the electromagnetic field of the 
impedance sensor, due to the increased positive charge associated with the ZnO crystals.
The greatest difference between the impedance values of the nano-surfaces at different concentration of ZnO 
occurred at a frequency of 138 Hz. This frequency was similar to frequencies used in the literature. For example, 
Jacobs et al.38 found that the most significant changes occurred around 100 Hz, when adding various concentra-
tions of the protein troponin-T on to a ZnO surface. Jacobs reported that this was due to the fact that the electrical 
double layer is greater at frequencies below 1000 Hz38. A statistical analysis of the impedance values taken at a 
frequency of 138 Hz is shown in Table 1. The %CVs demonstrate that the fabrication process is reliable as the 24 
measurements were performed on individual sensor surfaces. Although all surfaces were highly reproducible, the 
highest concentration of ZnO nano-crystals resulted in the highest reproducibility. At all concentrations, there 
was a highly significant difference between the impedance of bare PET material and the impedance of the PET 
with ZnO (p < 0.001).
Calibration curve comparison of the three ZnO-PET surfaces with CRP immobilised. To exam-
ine the effect of varying the incubation period, measurements were performed on 1% ZnO nano-surfaces pre-
pared with antibody and incubated for 5, 10, 15 minutes. Figure 6 shows the absolute value of the impedance as 
Figure 4. Raman spectra of ZnO nano-surface on PET (blue line) and ZnO with capture antibody on 
PET (green line). Conditions of recording ZnO with capture antibody on PET: time acquisition 150 s, laser 
wavelength 785 nm.
Figure 5. Impedance spectra of three different concentrations of ZnO nano-powders (blue: 5%, red: 1%, lime 
green: 0.5%) on PET substrates.
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a logarithmic function of CRP concentration for each of the 3 nano-surfaces. The plots were similar indicating 
that beyond 5 minutes the incubation time does not greatly influence the result, which suggests that binding of 
CRP to the antibody occurs rapidly. The dose dependent response of absolute impedance for each incubation 
time shows decreasing impedance with increasing CRP loading. This can be explained by the fact that in this 
experimental set-up the ZnO is positively charge, whereas the CRP is dominated by negative charge (pI of CRP is 
~5.45). Electrochemical impedance spectroscopy (EIS) can be used to measured an electrical double layer (EDL) 
formed when a semiconducting material interacts with liquid electrolytes11. Consequently, when binding to the 
ZnO occurs, through capture by the antibody on the surface, there is a decrease in the overall positive charge 
with increasing CRP loading and a decrease in the absolute impedance value. This observation concurs with the 
literature where it is reported that, for non-faradaic biosensors, changes in the surface dielectric and charge dis-
tribution are induced when a protein target binds to the receptor, previously attached in the electrode, displacing 
water and ions from the surface39.
The nano-surfaces fabricated from different ZnO suspensions were compared by measuring impedance 
changes with 100 ng capture antibody by adding different concentrations of CRP from 0 to 15 ng/ml at 138 Hz 
with 10 minutes incubation time. These experimental conditions were selected because, as described above, repro-
ducible differences between the samples were evident at 138 Hz. In addition, from Fig. 6, the absolute impedance 
measurement have shown to perform reliably with a 10 minutes incubation time. The modulus of the impedance 
differences (impedance value minus the blank) were employed to plot a calibration curve as shown in Fig. 7. The 
impedance difference plot shows increasing values of the modulus of the impedance difference with increasing 
concentrations of CRP for 0.5% and 1% ZnO nano-surfaces. A dose dependence relationship is shown for each 
plot and can be explained as for Fig. 6 (the opposite slope relating to the fact that Fig. 7 is the modulus of the dif-
ference, whereas Fig. 6 shows absolute impedance measurement).
EIS has been shown to be effective tool for probing the interfacial proporties such as the charge transfer and 
charge seperation7. Figure 7 shows that biosensors prepared with 1% ZnO gave higher output for each concen-
tration of CRP compared with 0.5%. The performance of the biosensors is related to the availability of antibody 
on the surface to bind CRP. Increasing concentrations of antigen binds to a fixed amount of antibody in a dose 
dependent manner defined by the binding affinity. We speculate that there is increased charge accumulation 
due to the bound antigen on the surface compared with the antigen in solution. In addition, there will be an 
increased amount of isolated antigen flowing freely in solution, resulting in a decrease in the charge carriers and 
hence resistance of the solution. Surfaces fabricated using 1% ZnO showed the highest roughness index implying 
it has the greatest surface area on which the anti-CRP antibody are captured. The low sensitivity of 0.5% ZnO 
nano-surafce is likely to be due to the fact that using 0.5% ZnO the PET surface is not fully covered and that the 
ZnO exists as “islands” of nanocrystals in a modified form due to the ultrasonication. Because of the thickness of 
the flatter 5% ZnO nano-surface, it was easy to break during the process of protein immobilization. Consequently, 
the impedance tests were unstable with big error bars and are excluded in Fig. 7.
Different concentrations 
of ZnO suspensions 
dropped on PET N Mean StDev CV(%)
5% 24 352870 2453 0.70
1% 24 345567 4117 1.19
0.5% 24 338387 5633 1.66
Table 1. Data analysis on impedance values on each set of ZnO nano-surfaces at fixed frequency.
Figure 6. Impedance values from 1% ZnO nano-sensors, with 100 ng capture antibody with increasing 
concentrations of antigen: 0–15 ng/ml, for 5, 10 and 15 minutes incubation time.
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From Fig. 7, it is evident that the limit of detection for 1% is better than 1 ng/ml. (Further work beyond this 
study is needed to optimise the biosensors and define the specific limit of detection value in each case.) In human 
blood the normal level of CRP is defined as being less than 10 mg/L which can rise to over 1000 mg/L in cases 
of severe bacterial infections. Recently the use of high sensitivity measurements of CRP has been shown to be 
valuable in determining risk of cardiovascular disease. A high sensitivity CRP test (hsCRP) can measure CRP at 
concentrations of 0.04 mg/L and levels of hsCRP greater than 3.0 mg/L (in the absence of inflammatory processes) 
is indicative of a high risk of developing cardiovascular disease. The biosensor described in this paper can meas-
ure down to 0.001 mg/L and has plenty of scope to allow for dilution of a small blood sample for presentation to 
a sensor surface and still be able to measure the small changes in CRP concentration related to risk of cardiovas-
cular disease. The biosensor described has the potential to be developed into a rapid, inexpensive diagnostic test 
for CRP.
Conclusion
Zinc oxide nano-surfaces can be created simply and at low cost using a new colloidal dispersion technique, incor-
porating sonication. Raman spectra of the surface indicated the ZnO crystal surfaces was highly ordered and uni-
form. Impedance analysis confirmed that the ZnO surfaces were highly reproducible, individual measurements 
being taken across many days. SEM analysis illustrated differences in the surfaces when three different ZnO sus-
pension concentrations were applied. The highest concentration studied (5% ZnO) showed the smoothest surface 
whereas the lowest concentration (0.5%) showed incomplete coverage of the substrate. 1% ZnO demonstrated 
full coverage of the surface and the largest surface area which was quantified by a roughness index. After addition 
of the antibody to the ZnO surface, Raman spectroscopy confirmed that there was coverage of ZnO surface with 
the IgG antibody.
At a fixed frequency of 138 Hz, a dose dependent response was observed from 0.1 ng/ml to 15 ng/ml CRP 
for all 3 concentrations of ZnO (5%, 1% and 0.5%). A limit of detection of less than 1 ng/ml was indicated for 
concentrations of 1%. 1% ZnO nano-surface showed the best results with the highest sensitivity. This may be 
explained by the fact that the 1% ZnO nano-surface has the highest roughness index of the 3 concentrations, cal-
culated from Fig. 2, and hence the largest surface area for binding. In contrast, the 0.5% ZnO nano-surface shows 
incomplete coverage, high variability of particle size and shape and also the lowest sensitivity. Interestingly, during 
biosensor preparation, the 1% ZnO nano-surface was more stable than 5% during the process of protein immobi-
lisation. The method for fabrication of ZnO nano-surface via colloidal dispersion coupled with ultra-sonication is 
simple and inexpensive and we consider that this is a promising area for future research. Further work is required 
to fully characterise the biosensor and to optimise the process of fabricating nano-surface and protein immobili-
sation to confirm the excellent reproducibility.
Methods
Materials. Zinc oxide nanopowders (ZnO, 99.9 + %, 80–200 nm) were purchased from US Research 
Nanomaterials Inc. Biological molecules: monoclonal mouse anti-human C-reactive protein (4C28 Mab: C6) 
and human C-reactive protein (CRP) (8C72) were purchased from HyTest Ltd. Phosphate Buffered Saline (PBS, 
pH 7.3 ± 0.2 at 25 °C was purchased from OXOID Microbiology products. The PBS buffer was diluted to 0.025 M 
adjusting the pH to 7.4.
Surface preparation. Accurately weighed quantities of ZnO nano-crystals were added to double deionized 
water to make a range of concentrations of ZnO suspensions: 0.5%, 1% and 5%. The ZnO suspensions were 
stirred for one hour and then 1.5 ml aliquots were ultra-sonicated for 7 periods of 20 seconds, at 4 minutes inter-
vals using an exponential microprobe (Soniprep 150) at 30 watts. 200 μl ZnO suspensions were dropped onto 
Figure 7. Impedance change in response to increasing concentrations of antigen on 0.5% and 1% ZnO nano-
surfaces with 100 ng capture antibody (n = 3).
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clean polyethylene terephthalate (PET) surface. Subsequently, they were dried in oven at 65 °C for 80 minutes and 
cooled to room temperature and stored in a dry atmosphere with silica gel for up to 2 days.
CRP Sensor fabrication and test. The sensing area (10 × 4 mm) of ZnO nanoparticles was defined by 
tapes (Fig. 8a). Subsequently, 40 μl (100 ng) antibody (C6) was added to the surface (Fig. 8b). The biosensor was 
then dried in a desiccator with silica gel at 4 °C overnight for 18 hours (Fig. 8c) without wash.
A Cypher Instruments C60 Impedance-Amplitude-Phase Analyser was used to measure the impedance of the 
nano-crystal surfaces (Fig. 8f). The frequency was scanned from 10 Hz to 4 MHz at a voltage of 2 Vpp, and a DC 
offset of 0.9 mV, with 300 test points. The impedance plots were analysed using Cypher Graph V1.21.0, Impedance 
Amplitude and Phase Analyser graphing application software. Impedance spectra of ZnO nano-surfaces were 
acquired on 24 independent measurements at each of the three concentrations of ZnO used to prepare the surface.
Statistical tests were performed using Minitab. The %CV = (Standard Deviation/Mean*100) was used to com-
pare variation and demonstrate reproducibility within groups. A 2-Sample t-test for between group comparisons 
was used to prove significant differences, a p value of <0.05 was considered significant.
CRP was prepared at a range of concentrations: 0 (PBS only), 1, 2.5, 5, 10, and 15 ng/ml in PBS (Fig. 8d). 75 μl 
of each concentration of antigen was added to the biosensor (Fig. 8e) without wash. Following set incubation 
times the impedance was measured (Fig. 8g) without wash. Impedance measurements were also made at each 
stage of the assay process, namely: (1) On the nano-crystal surfaces with dry antibody; (2) Instantly, after adding 
75 μl of different concentrations of antigen and (3) at 5 minutes intervals until 30 minutes incubation time had 
passed. In order to plot logarithmic concentrations of CRP, the measurement of PBS buffer only with no CRP (the 
blank), was defined 0.1 ng/ml CRP (rather than 0 ng/ml). The difference in impedance was derived by subtracting 
the blank impedance value from each impedance measurement of the CRP assay at the various concentrations.
Characterization. The morphology of ZnO nano-surface was analysed by Scanning Electron Microscopy 
(SEM). The samples were coated with a thin layer of Au prior to analysis. A grayscale profile of each image was 
created using Image J software. Grayscale values along a horizontal line comprising 966 points, were used to pro-
duce a’Roughness Index’. A grayscale value (0–255) is a single number that represents the brightness of the pixel. 
The light areas indicate charge on the surface in the SEM with higher points reflecting electrons and accumulating 
charge more easily. This means that “deeper” areas do not reflect or accumulate charge as readily and conse-
quently have lower values. Roughness Index was defined as the summation of absolute changes in grayscale values 
between each two adjacent points. Consequently, the Roughness Index gives an indication of surface area; a larger 
index means a larger surface area. Grayscale value plots were derived from the images shown in Fig. 1(a,b,c) by 
placing a horizontal line across the image using ImageJ software, as shown in Fig. 2.
Raman spectroscopy was used to distinguish the chemical compositions of the ZnO nano-crystal surfaces. A 
XploRA Raman spectrometer from Horiba, equipped with a confocal microscope, was used. The Raman signals 
were collected in a range of 0–3500 cm−1 using a 785 nm red laser excitation. The laser beam was focused on the 
sample using objective magnification of 50×.
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